Skip to main content
. 2019 Jul 30;7(4):340–344. doi: 10.1016/j.ajur.2019.07.005

Table 1.

Anticoagulant and anti-platelet use.

Agent Patients, n (%)
Aspirin 4 (20%)
Clopidogrel 3 (17%)
Warfarin 2 (10%)
Apixaban 6 (30%)
Dabigatran 10 (50%)
Rivaroxaban 4 (20%)